We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Capnography Monitoring Solution Increases Patient Safety

By HospiMedica International staff writers
Posted on 31 Oct 2013
A new capnography solution offers enhanced features that could help clinicians identify and address serious respiratory care threats sooner.

The Capnostream 20p bedside monitor features the proprietary Apnea-Sat Alert algorithm, an algorithm that measures and reports recurring apnea and oxygen desaturation events, displaying the values directly on the Capnostream 20p monitor screen without requiring additional equipment or clinical workflow changes. More...
Apnea-Sat Alert technology is also part of the broader family of Smart Alarm Management integrated algorithms that help to mitigate alarm fatigue, including Smart Breath Detection, a filter and pattern recognition algorithm that screens out low-amplitude “non-breath” etCO2 excursions like snoring, talking or crying, to provide a more accurate respiratory rate.

Other integrated algorithms include Smart Alarm for Respiratory Analysis (SARA), an alarm management technology that helps prevent alarm fatigue by reducing clinically insignificant respiratory alarms; Nellcor SatSeconds, a technology that helps analyze oxygen desaturation events; and the Integrated Pulmonary Index (IPI) algorithm that combines four respiratory measurements—capnography, respiratory rate, pulse rate, and pulse oximetry—to provide clinicians with an integrated snapshot of respiratory status.

The Capnostream 20p bedside monitor also includes the Microstream-enabled microMediCO2 module measurement bench, a module that offers easy integration into host monitor configurations, and is designed to support future Smart Capnography algorithms without requiring hardware upgrades. The Capnostream 20p bedside monitor is a product of Covidien (Dublin, Ireland), and has been approved by the US Food and drug Administration (FDA).

“Studies show that as many as 88% of hospitalized patients may be at risk for recurrent apneas, yet we’re only identifying and treating a very small number,” said Scott Kelley, MD, chief medical officer of respiratory and monitoring solutions at Covidien. “The Capnostream 20p bedside monitor will help increase apnea detection rates and represents an important advancement in continuous patient monitoring that we believe will help save lives.”

Related Links:

Covidien



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Warming Cabinet
EC1850BL
New
Anesthetic Gas Measurement Module
Scio Four
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.